Header Logo

Elisabeth A.Tallant PhD

TitleProfessor
InstitutionWake Forest School of Medicine
DepartmentSurgery, Hypertension
Address
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionWake Forest School of Medicine
    DepartmentCancer Biology

    TitleAssistant Director
    InstitutionWake Forest School of Medicine
    DepartmentHypertension & Vascular Research Center


    Collapse Research 
    Collapse research activities and funding
    R01NS031664     (TALLANT, ELISABETH ANN)Aug 1, 1992 - Jul 31, 2001
    NIH
    CELLULAR MECHANISMS FOR ANGIOTENSIN RESPONSES IN BRAIN
    Role: Principal Investigator

    R03CA103098     (TALLANT, ELISABETH ANN)Jul 1, 2003 - Jun 30, 2006
    NIH
    Prevention of Lung Cancer Growth by Angiotensin-(1-7)
    Role: Principal Investigator

    R25HL092618     (TALLANT, ANN ANN)Apr 15, 2008 - Jan 31, 2023
    NIH
    Excellence in Cardiovascular Sciences Summer Research
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wester A, Devocelle M, Tallant EA, Chappell MC, Gallagher PE, Paradisi F. Stabilization of Angiotensin-(1-7) by key substitution with a cyclic non-natural amino acid. Amino Acids. 2017 10; 49(10):1733-1742. PMID: 28744580.
      Citations:    
    2. Willey JS, Bracey DN, Gallagher PE, Tallant EA, Wiggins WF, Callahan MF, Smith TL, Emory CL. Angiotensin-(1-7) Attenuates Skeletal Muscle Fibrosis and Stiffening in a Mouse Model of Extremity Sarcoma Radiation Therapy. J Bone Joint Surg Am. 2016 Jan 06; 98(1):48-55. PMID: 26738903.
      Citations:    
    3. Gwathmey TM, Tallant EA, Howlett AC, Diz DI. Programs to Recruit and Retain a More Diverse Workforce in Biomedical Sciences Research. J Best Pract Health Prof Divers. 2016; 9(1):1188-1194. PMID: 28868526.
      Citations:    
    4. Carver KA, Smith TL, Gallagher PE, Tallant EA. Angiotensin-(1-7) prevents angiotensin II-induced fibrosis in cremaster microvessels. Microcirculation. 2015 Jan; 22(1):19-27. PMID: 25079175.
      Citations:    
    5. Gallagher PE, Arter AL, Deng G, Tallant EA. Angiotensin-(1-7): a peptide hormone with anti-cancer activity. Curr Med Chem. 2014; 21(21):2417-23. PMID: 24524765.
      Citations:    
    6. Nautiyal M, Katakam PV, Busija DW, Gallagher PE, Tallant EA, Chappell MC, Diz DI. Differences in oxidative stress status and expression of MKP-1 in dorsal medulla of transgenic rats with altered brain renin-angiotensin system. . 2012 Oct 15; 303(8):R799-806. PMID: 22914751.
      Citations:    
    7. Krishnan B, Torti FM, Gallagher PE, Tallant EA. Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1. Prostate. 2013 Jan; 73(1):60-70. PMID: 22644934.
      Citations:    
    8. Krishnan B, Smith TL, Dubey P, Zapadka ME, Torti FM, Willingham MC, Tallant EA, Gallagher PE. Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis. Prostate. 2013 Jan; 73(1):71-82. PMID: 22644942.
      Citations:    
    9. McCollum LT, Gallagher PE, Tallant EA. Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts. Peptides. 2012 Apr; 34(2):380-8. PMID: 22326709.
      Citations:    
    10. McCollum LT, Gallagher PE, Ann Tallant E. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1. . 2012 Feb 01; 302(3):H801-10. PMID: 22140049.
      Citations:    
    11. Gallagher PE, Cook K, Soto-Pantoja D, Menon J, Tallant EA. Angiotensin peptides and lung cancer. Curr Cancer Drug Targets. 2011 May; 11(4):394-404. PMID: 21395552.
      Citations:    
    12. Diz DI, Arnold AC, Nautiyal M, Isa K, Shaltout HA, Tallant EA. Angiotensin peptides and central autonomic regulation. Curr Opin Pharmacol. 2011 Apr; 11(2):131-7. PMID: 21367658.
      Citations:    
    13. Cook KL, Metheny-Barlow LJ, Tallant EA, Gallagher PE. Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors. Cancer Res. 2010 Nov 01; 70(21):8319-28. PMID: 20837666.
      Citations:    
    14. Varagic J, Ahmad S, Brosnihan KB, Groban L, Chappell MC, Tallant EA, Gallagher PE, Ferrario CM. Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction. Ther Adv Cardiovasc Dis. 2010 Feb; 4(1):17-25. PMID: 19946038.
      Citations:    
    15. Petty WJ, Miller AA, McCoy TP, Gallagher PE, Tallant EA, Torti FM. Phase I and pharmacokinetic study of angiotensin-(1-7), an endogenous antiangiogenic hormone. Clin Cancer Res. 2009 Dec 01; 15(23):7398-404. PMID: 19920106.
      Citations:    
    16. Soto-Pantoja DR, Menon J, Gallagher PE, Tallant EA. Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. . 2009 Jun; 8(6):1676-83. PMID: 19509262.
      Citations:    
    17. Gallagher PE, Ferrario CM, Tallant EA. Regulation of ACE2 in cardiac myocytes and fibroblasts. . 2008 Dec; 295(6):H2373-9. PMID: 18849338.
      Citations:    
    18. Gallagher PE, Ferrario CM, Tallant EA. MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides. . 2008 Nov; 295(5):C1169-74. PMID: 18768926.
      Citations:    
    19. Diz DI, Garcia-Espinosa MA, Gegick S, Tommasi EN, Ferrario CM, Ann Tallant E, Chappell MC, Gallagher PE. Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats. Exp Physiol. 2008 May; 93(5):694-700. PMID: 18356558.
      Citations:    
    20. Menon J, Soto-Pantoja DR, Callahan MF, Cline JM, Ferrario CM, Tallant EA, Gallagher PE. Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2. Cancer Res. 2007 Mar 15; 67(6):2809-15. PMID: 17363603.
      Citations:    
    21. Whaley-Connell AT, Chowdhury NA, Hayden MR, Stump CS, Habibi J, Wiedmeyer CE, Gallagher PE, Tallant EA, Cooper SA, Link CD, Ferrario C, Sowers JR. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat. Am J Physiol Renal Physiol. 2006 Dec; 291(6):F1308-14. PMID: 16788142.
      Citations:    
    22. Jessup JA, Gallagher PE, Averill DB, Brosnihan KB, Tallant EA, Chappell MC, Ferrario CM. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats. . 2006 Nov; 291(5):H2166-72. PMID: 16766648.
      Citations:    
    23. Tallant EA, Ferrario CM, Gallagher PE. Cardioprotective role for angiotensin-(1-7) and angiotensin converting enzyme 2 in the heart. Future Cardiol. 2006 May; 2(3):335-42. PMID: 19804091.
      Citations:    
    24. Gallagher PE, Chappell MC, Ferrario CM, Tallant EA. Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. . 2006 Feb; 290(2):C420-6. PMID: 16176966.
      Citations:    
    25. Tallant EA, Ferrario CM, Gallagher PE. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. . 2005 Oct; 289(4):H1560-6. PMID: 15951342.
      Citations:    
    26. Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005 May 24; 111(20):2605-10. PMID: 15897343.
      Citations:    
    27. Richmond RS, Tallant EA, Gallagher PE, Ferrario CM, Strawn WB. Angiotensin II stimulates arachidonic acid release from bone marrow stromal cells. J Renin Angiotensin Aldosterone Syst. 2004 Dec; 5(4):176-82. PMID: 15803435.
      Citations:    
    28. Gallagher PE, Tallant EA. Inhibition of human lung cancer cell growth by angiotensin-(1-7). Carcinogenesis. 2004 Nov; 25(11):2045-52. PMID: 15284177.
      Citations:    
    29. Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension. 2004 May; 43(5):970-6. PMID: 15007027.
      Citations:    
    30. Tallant EA, Clark MA. Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). Hypertension. 2003 Oct; 42(4):574-9. PMID: 12953014.
      Citations:    
    31. Clark MA, Tallant EA, Tommasi E, Bosch S, Diz DI. Angiotensin-(1-7) reduces renal angiotensin II receptors through a cyclooxygenase-dependent mechanism. J Cardiovasc Pharmacol. 2003 Feb; 41(2):276-83. PMID: 12548089.
      Citations:    
    32. Clark MA, Tallant EA, Diz DI. Downregulation of the AT1A receptor by pharmacologic concentrations of Angiotensin-(1-7). J Cardiovasc Pharmacol. 2001 Apr; 37(4):437-48. PMID: 11300657.
      Citations:    
    33. Clark MA, Diz DI, Tallant EA. Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells. Hypertension. 2001 Apr; 37(4):1141-6. PMID: 11304516.
      Citations:    
    34. Tallant EA, Diz DI, Ferrario CM. State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle. Hypertension. 1999 Oct; 34(4 Pt 2):950-7. PMID: 10523390.
      Citations:    
    35. Strawn WB, Gallagher PE, Tallant EA, Ganten D, Ferrario CM. Angiotensin II AT1-receptor blockade inhibits monocyte activation and adherence in transgenic (mRen2)27 rats. J Cardiovasc Pharmacol. 1999 Mar; 33(3):341-51. PMID: 10069667.
      Citations:    
    36. Strawn WB, Ferrario CM, Tallant EA. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension. 1999 Jan; 33(1 Pt 2):207-11. PMID: 9931106.
      Citations:    
    37. Brosnihan KB, Li P, Tallant EA, Ferrario CM. Angiotensin-(1-7): a novel vasodilator of the coronary circulation. Biol Res. 1998; 31(3):227-34. PMID: 9830510.
      Citations:    
    38. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI. Counterregulatory actions of angiotensin-(1-7). Hypertension. 1997 Sep; 30(3 Pt 2):535-41. PMID: 9322978.
      Citations:    
    39. Tallant EA, Higson JT. Angiotensin II activates distinct signal transduction pathways in astrocytes isolated from neonatal rat brain. Glia. 1997 Apr; 19(4):333-42. PMID: 9097077.
      Citations:    
    40. Tallant EA, Lu X, Weiss RB, Chappell MC, Ferrario CM. Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension. 1997 Jan; 29(1 Pt 2):388-93. PMID: 9039132.
      Citations:    
    41. Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension. 1996 Jul; 28(1):104-8. PMID: 8675248.
      Citations:    
    42. Tallant EA, Diz DI, Ferrario CM. Identification of AT1 receptors on cultured astrocytes. Adv Exp Med Biol. 1996; 396:121-9. PMID: 8726692.
      Citations:    
    43. Freeman EJ, Ferrario CM, Tallant EA. Angiotensins differentially activate phospholipase D in vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats. Am J Hypertens. 1995 Nov; 8(11):1105-11. PMID: 8554734.
      Citations:    
    44. Moriguchi A, Tallant EA, Matsumura K, Reilly TM, Walton H, Ganten D, Ferrario CM. Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats. Hypertension. 1995 Jun; 25(6):1260-5. PMID: 7768571.
      Citations:    
    45. Chappell MC, Jacobsen DW, Tallant EA. Characterization of angiotensin II receptor subtypes in pancreatic acinar AR42J cells. Peptides. 1995; 16(4):741-7. PMID: 7479311.
      Citations:    
    46. Freeman EJ, Tallant EA. Vascular smooth-muscle cells contain AT1 angiotensin receptors coupled to phospholipase D activation. Biochem J. 1994 Dec 01; 304 ( Pt 2):543-8. PMID: 7998990.
      Citations:    
    47. Jaiswal N, Jaiswal RK, Tallant EA, Diz DI, Ferrario CM. Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells. Hypertension. 1993 Jun; 21(6 Pt 2):900-5. PMID: 8505098.
      Citations:    
    48. Jaiswal N, Tallant EA, Jaiswal RK, Diz DI, Ferrario CM. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved. J Pharmacol Exp Ther. 1993 May; 265(2):664-73. PMID: 8496814.
      Citations:    
    49. Ferrario CM, Brosnihan KB, Diz DI, Jaiswal N, Khosla MC, Milsted A, Tallant EA. Angiotensin-(1-7): a new hormone of the angiotensin system. Hypertension. 1991 Nov; 18(5 Suppl):III126-33. PMID: 1937675.
      Citations:    
    50. Tallant EA, Jaiswal N, Diz DI, Ferrario CM. Human astrocytes contain two distinct angiotensin receptor subtypes. Hypertension. 1991 Jul; 18(1):32-9. PMID: 1860709.
      Citations:    
    51. Jaiswal N, Tallant EA, Diz DI, Khosla MC, Ferrario CM. Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension. 1991 Jun; 17(6 Pt 2):1115-20. PMID: 2045158.
      Citations:    
    52. Tallant EA, Diz DI, Khosla MC, Ferrario CM. Identification and regulation of angiotensin II receptor subtypes on NG108-15 cells. Hypertension. 1991 Jun; 17(6 Pt 2):1135-43. PMID: 2045160.
      Citations:    
    53. Jaiswal N, Diz DI, Tallant EA, Khosla MC, Ferrario CM. Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells. Am J Physiol. 1991 May; 260(5 Pt 2):R1000-6. PMID: 2035693.
      Citations:    
    54. Jaiswal N, Diz DI, Tallant EA, Khosla MC, Ferrario CM. The nonpeptide angiotensin II antagonist DuP 753 is a potent stimulus for prostacyclin synthesis. Am J Hypertens. 1991 Mar; 4(3 Pt 1):228-33. PMID: 2043299.
      Citations:    
    55. Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM. Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line. Peptides. 1990 Mar-Apr; 11(2):375-80. PMID: 2162536.
      Citations:    
    Tallant's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (254)
    Explore
    _
    Co-Authors (14)
    Explore
    _
    Similar People (55)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _